Retaglutide is a innovative GLP-1 receptor agonist currently under study for the treatment of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://theoxdjg053892.post-blogs.com/59672660/retaglutide-a-promising-glp-1-receptor-agonist